Mad in America
NOVEMBER 13, 2023
In 1990-92, 12% of the US population aged 18–54 years received treatment for emotional problems, which went up to 20% in 2001–2003. Avoid financial conflicts of interest with manufacturers of psychoactive drugs or other treatments, e.g. equipment for electroshock.
Mad in America
MARCH 11, 2025
An internal report by drugs firm GSK , which makes the medication, reveals the manufacturer was aware of the link with impulsive behaviours in 2003. This information was shared with drug regulators, according to GSK. In 2011, a class action was brought against GSK by four sufferers of Parkinson’s disease.
Mad in America
FEBRUARY 11, 2025
2021; Read & Harrop, 2022; Read & Moncrieff, 2022; Reisner, 2003; Roche, 2016; Rogers, 2021; Schwartzkopff, 2020; Simonson, 2020; Singh, 2016; Sweetmore, 2022; Teixeira, 2020). Electroconvulsive Therapy, Manufacturers Liability, and Learned Intermediaries. ECT is still controversial (Alibhai, 2022; Archer et al., Gardner, H.,
Expert insights. Personalized for you.
142 
Let's personalize your content